Loblaw A - Search Results

1

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.

Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators. Brand DH, et al. Among authors: loblaw a. Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17. Lancet Oncol. 2019. PMID: 31540791 Free PMC article. Clinical Trial.

2

Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers.

Hird A, Chow E, Zhang L, Wong R, Wu J, Sinclair E, Danjoux C, Tsao M, Barnes E, Loblaw A. Hird A, et al. Among authors: loblaw a. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):193-7. doi: 10.1016/j.ijrobp.2008.10.044. Epub 2009 Jan 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19167840

3

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Morton G, Loblaw A, Cheung P, Szumacher E, Chahal M, Danjoux C, Chung HT, Deabreu A, Mamedov A, Zhang L, Sankreacha R, Vigneault E, Springer C. Morton G, et al. Among authors: loblaw a. Radiother Oncol. 2011 Sep;100(3):463-7. doi: 10.1016/j.radonc.2011.08.022. Epub 2011 Sep 14. Radiother Oncol. 2011. PMID: 21924511 Clinical Trial.

4

Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.

Sethukavalan P, Cheung P, Tang CI, Quon H, Morton G, Nam R, Loblaw A. Sethukavalan P, et al. Among authors: loblaw a. Can J Urol. 2012 Apr;19(2):6165-9. Can J Urol. 2012. PMID: 22512958

5

Intensity-modulated radiotherapy in the treatment of prostate cancer.

Bauman G, Rumble RB, Chen J, Loblaw A, Warde P; Members of the IMRT Indications Expert Panel. Bauman G, et al. Among authors: loblaw a. Clin Oncol (R Coll Radiol). 2012 Sep;24(7):461-73. doi: 10.1016/j.clon.2012.05.002. Epub 2012 Jun 4. Clin Oncol (R Coll Radiol). 2012. PMID: 22673744 Review.

6

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes.

Loblaw A, Cheung P, D'Alimonte L, Deabreu A, Mamedov A, Zhang L, Tang C, Quon H, Jain S, Pang G, Nam R. Loblaw A, et al. Radiother Oncol. 2013 May;107(2):153-8. doi: 10.1016/j.radonc.2013.03.022. Epub 2013 May 3. Radiother Oncol. 2013. PMID: 23647750 Clinical Trial.

7

Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial.

Chiang A, Zeng L, Zhang L, Lochray F, Korol R, Loblaw A, Chow E, Sahgal A. Chiang A, et al. Among authors: loblaw a. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):638-42. doi: 10.1016/j.ijrobp.2013.03.022. Epub 2013 May 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 23664326 Clinical Trial.

8

The value of randomised trials for prostate cancer management.

Loblaw A. Loblaw A. Lancet Oncol. 2014 Apr;15(4):374-5. doi: 10.1016/S1470-2045(14)70081-6. Epub 2014 Feb 26. Lancet Oncol. 2014. PMID: 24581939 Free article. No abstract available.

9

Emerging applications of stereotactic body radiotherapy.

Lo SS, Loblaw A, Chang EL, Mayr NA, Teh BS, Huang Z, Yao M, Ellis RJ, Biswas T, Sohn JW, Machtay M, Sahgal A. Lo SS, et al. Among authors: loblaw a. Future Oncol. 2014 May;10(7):1299-310. doi: 10.2217/fon.14.13. Future Oncol. 2014. PMID: 24947266 Review.

10

Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapy.

Elias E, Helou J, Zhang L, Cheung P, Deabreu A, D'Alimonte L, Sethukavalan P, Mamedov A, Cardoso M, Loblaw A. Elias E, et al. Among authors: loblaw a. Radiother Oncol. 2014 Jul;112(1):83-8. doi: 10.1016/j.radonc.2014.06.009. Epub 2014 Jul 5. Radiother Oncol. 2014. PMID: 25005578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page